US Generics Market: Industry Trends, Competitive Landscape, Opportunities and Outlook

Imarc www.imarcgroup.com

Copyright © 2015 International Market Analysis Research & Consulting (IMARC). All Rights Reserved

Consulting Services

The International Market Analysis Research and Consulting Group is a leading advisor on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

About IMARC GroupImarc www.imarcgroup.com

Report Description and HighlightsImarc www.imarcgroup.com

US Generics Market: Industry Trends and Opportunities 

A number of factors have catalyzed the strong growth in the US generics market. This includes their low costs, drug patent expiries, cost savings for governments’ and payers’, lower copayments for patients, ageing population and an increasing prevalence of chronic diseases.

The United States represents the world’s biggest market for generic drugs. Over the past three decades, the acceptance and use of generics in the United States has changed markedly. This transformation has been catalyzed by a number of factors. The continuous expiration of drug patents, rising aging population, increasing prevalence of chronic diseases and continuous efforts by governments and health care service providers to control their healthcare expenditures have enabled generics to represent a multibillion dollar industry in the United States.

The report entitled “US Generics Market: Industry Trends, Competitive Landscape, Opportunities and Outlook” represents an in-depth analysis on the historical, current and future trends in the US generics market. This research report serves as an exceptional tool to understand the drivers, sales trends, prescription trends, market structure, competitive landscape, regulations, key players, key drugs, manufacturing and the outlook of the US generics market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who want to gain an insight into the US generics market in any form.

Report Description and HighlightsImarc www.imarcgroup.com

Key Questions Answered in This Report?

• What are generic drugs and how are they different from branded drugs?• How have the US generics market performed in recent years?• How have generics performed compared to branded drugs?• What were the total sales and prescriptions for generics in the US?• Who are the key players in the US generics market and how have they performed?• What is the structure of the US generics market?• Which are the most prescribed generics in the US?• What is the pricing mechanism of generics in the US?• What is the value chain of generics in the US?• What are the regulations for generics in the US?• How are generics distributed in the US?• How are generics manufactured?• What are the raw material and machinery requirements to manufacture generics?• What are the drivers and challenges in the US generics market?

Table of Contents

1 Research Methodology and Market Definitions2 Report Summary3 US Generics Market - Introduction3.1 What are Generics?3.2 Unbranded and Branded Generics3.3 Authorized Generics

US Generics MarketImarc www.imarcgroup.com

Report Description and HighlightsImarc www.imarcgroup.com

3.4 Commoditised and Specialty Generics4 Why is the US Generics Market so Lucrative4.1 Patent Expiry of Blockbuster Drugs4.2 Significant Price Differential Between Generics and Innovator Drugs4.3 Savings for the Government and Third Party Payers4.4 Incentives for Dispensing and Prescribing Generics4.5 Reimbursement and Lower Copayments4.6 Biosimilars5 Global Generics Market5.1 Current and Historical Market Trends5.2 Market Breakup by Country: The United States Represents the World’s Biggest Market5.3 Market Forecast6 US Generics Market6.1 US Pharmaceutical Market - Current and Historical Market Trends6.2 US Pharmaceutical Market - Share of Branded and Generic Drugs6.3 US Generics Market - Current and Historical Sales Trends6.4 US Generics Market - Current and Historical Volume Trends6.5 US Generics Market - Market Breakup By Segment7 US Generics Market- Competitive Landscape7.1 US Generics Market - Competitive Structure7.2 US Generics Market - Sales Breakup of Key Players7.3 US Generics Market - Volume Breakup of Key Players7.4 US Generics Market - Most Prescribed Generic Drugs7.5 US Generics Market - Market Breakup By Distribution7.6 US Generics Market - Pricing Dynamics

Report Description and HighlightsImarc www.imarcgroup.com

8 US Generics Market - Value Chain Analysis8.1 Research and Development8.2 Manufacturing8.3 Marketing and Distribution9 Regulations in the US Generics Industry9.1 Overview of Pharmaceutical Regulations9.2 Drug Applications9.3 Patents and Market Exclusivity9.4 Regulatory Requirement For Generics9.5 The Hatch-Waxman Act9.6 Possible Certifications9.7 Other Important Considerations10 US Generics Market: Key Success Factors11 US Generics Market: Road Blocks12 Requirements for Setting Up a Generic Drug Manufacturing Plant12.1 Manufacturing Process12.2 Raw Material Requirements12.3 Machinery and Infrastructure Requirements13 US Generic Market - Key Company Profiles13.1 Teva13.2 Mylan13.3 Actavis13.4 Sandoz13.5 Sun Pharma13.6 Par Pharmaceuticals

Report Description and HighlightsImarc www.imarcgroup.com

13.7 Endo Pharmaceuticals13.8 Lupin Pharmaceuticals13.9 Dr Reddy’s13.10 Hospira List of Figures

Figure 3 1: Structure of the Pharmaceutical IndustryFigure 3 2: Classification of GenericsFigure 4 1: United States: Patent Expiry Exposure (in Billion US$), 2009-2018Figure 4 2: United States: Savings From Generic Drugs (in Billion US$), 2004-2014Figure 5 1: Global: Generics Market: Sales Value (in Billion US$), 2010-2014Figure 5 2: Global: Generics Market: Sales Volume (in Billion SU), 2010-2014Figure 5 3: Global: Generics Market: Sales Value Breakup By Country (in %), 2014Figure 5 4: Global: Generics Market: Sales Volume Breakup by Country (in %), 2014Figure 5 5: Global: Generics Market Forecast: Sales Value (in Billion US$), 2015-2020Figure 5 6: Global: Generics Market: Sales Volume (in Billion SU), 2015-2020Figure 6 1: US: Pharmaceutical Market: Sales Volume (in Million Prescriptions), 2010-2014Figure 6 2: US: Pharmaceutical Market: Sales Value (in US$ Billion), 2010-2014Figure 6 3: US: Pharmaceutical Market: Sales Volume Breakup of Branded and Generic Drugs (in %), 2010 & 2014Figure 6 4: US: Pharmaceutical Market: Sales Value Breakup of Branded and Generic Drugs (in %), 2010 & 2014Figure 6 5: US: Generics Market: Sales Value (in Billion US$), 2010-2014Figure 6 6: US: Generics Market Forecast: Sales Value (in US$ Billion), 2015-2020

Report Description and HighlightsImarc www.imarcgroup.com

Figure 6 7: US: Generics Market: Sales Volume (in Million Prescriptions), 2010-2014Figure 6 8: US: Generics Market Forecast: Sales Volume (in Million Prescriptions), 2015-2020Figure 6 9: US: Generics Market: Market Breakup by Segment (in %), 2010-2014Figure 7 1: United States: Generics Market: Sales Share of Top Players (in %), 2014Figure 7 2: United States: Generics Market: Volume Share of Top Players (in %), 2014Figure 7 3: United States: Generics Market: Volume Share by Distribution (in %), 2014Figure 7 4: United States: Generic Drug Prices as a Percentage of Branded Drug Prices – Based on Number of Competitors (in Billion US$)Figure 8 1: United States – Generics Market – Value Chain Analysis List of Tables

Table 4 1: United States: Sales and Patent Expiry of Major Drugs Expected to Lose Patent Protection (in Billion US$), 2016-2020Table 5 1: Global - Generics Market: Sales, Volume and Growth of Major Markets, 2014Table 7 1: United States: Generics Market: Sales Performance of Top Players (in US$ Million), 2014Table 7 2: United States: Generics Market: Volume Performance of Top Players (in Million Prescriptions), 2014Table 7 3: United States: Generics Market: Volume Performance of Top Generic Drugs (in Million Prescriptions), 2014Table 9 1: United States: Overview of Pharmaceutical Regulations

Report Description and HighlightsImarc www.imarcgroup.com

To buy the complete report or to get a free sample, please contact:

IMARC Group Asia:Email: apac@imarcgroup.comPhone: +91-120-415-5099

IMARC Group North America:Email: america@imarcgroup.comPhone: +1-631-791-1145

IMARC Group Europe, Middle East & Africa:Email: ema@imarcgroup.comPhone: +44-702-409-7331

To know more please visit: http://www.imarcgroup.com/us-generics-market

Report Description and HighlightsImarc www.imarcgroup.com

© 2015 IMARC All Rights Reserved

This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC).

Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.

IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

FOR MORE DETAILSVisit us at :

http://www.imarcgroup.com

Stay With Us:

TELEPHONE: +91-120-4155099 E-MAIL: sales@imarcgroup.com

Imarc www.imarcgroup.com